Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure
11:00am, Friday, 09'th May 2025
DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins, leading me to lower my rating from buy to hold. Despite demographic tailwinds and a growing market, gr
DexCom Stock: Earnings Beat and New Market Access Drive Bull Case
07:31am, Thursday, 08'th May 2025
DexCom, Inc. NASDAQ: DXCM has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) market, delivering outstanding first-quarter 2025 financial results that unders
5 Best Stocks of the S&P 500 ETF in the Past Month
11:50am, Monday, 05'th May 2025
The S&P 500 is enjoying its longest winning streak since 2004. We have highlighted the five best stocks in the S&P 500 over the past month.
DexCom: Growth Is Reaccelerating But Don't Ignore The Risks
04:34am, Monday, 05'th May 2025
I initially rated DexCom's stock as sell due to competition and GLP-1 threats, but surprising 1Q25 growth prompts an upgrade to hold. DXCM posted better than expected growth figures in 1Q25, establish
DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins
02:25pm, Friday, 02'nd May 2025
DXCM's first-quarter 2025 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by global growth in CGM adoption, strong Sensor sales and expansion into new marke
Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism
01:43pm, Friday, 02'nd May 2025
Nasdaq jumps as Dexcom, Palantir, and ON Semi soar. Jobs report beats forecasts, easing inflation fears and driving US stock market optimism.
Dexcom Stock Is Today's Big Winner After Earnings. Why the Medtech Is Soaring.
11:53am, Friday, 02'nd May 2025
Dexcom, the maker of glucose monitors for patients with diabetes, reports a strong first quarter.
2 Growth Stocks to Buy and Hold for a Decade
04:16am, Friday, 02'nd May 2025
Marketwide challenges, like those created by President Donald Trump's tariff policies, cause many investors to shift their focus to the short term -- leading to panic-selling and a spiraling stock mar
DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript
09:04pm, Thursday, 01'st May 2025
DexCom, Inc. (NASDAQ:DXCM ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Sean Christensen - VP, Finance & IR Kevin Sayer - Executive Chairman, CEO & President Jereme Sy
Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics
06:30pm, Thursday, 01'st May 2025
Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street e
DexCom (DXCM) Q1 Earnings Miss Estimates
06:20pm, Thursday, 01'st May 2025
DexCom (DXCM) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago.
Dexcom beats quarterly sales estimates, reiterates annual forecast
04:54pm, Thursday, 01'st May 2025
Medical device maker Dexcom beat first-quarter sales estimates helped by strong demand for its continuous glucose monitors (CGMs) used by patients with diabetes.
Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program
04:02pm, Thursday, 01'st May 2025
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program.
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
11:55am, Wednesday, 30'th Apr 2025
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
Gear Up for DexCom (DXCM) Q1 Earnings: Wall Street Estimates for Key Metrics
10:21am, Tuesday, 29'th Apr 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for DexCom (DXCM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
